Investors reacted positively to the news, as the FDA’s approval not only enhances Novavax’s product offering but also solidifies its partnership with Sanofi, a key player in the vaccine market. The ...

Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics ...

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

The appointment of a vocal critic of expedited approvals of vaccines, Vinay Prasad, to run the FDA’s office responsible for ...

The early months of Donald Trump’s presidency have brought sweeping changes to the country’s scientific and medical landscape ...

The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s COVID-19 vaccine, restricting its use to ...

Høeg has been skeptical of the safety and value of some vaccines and mandates, raising questions about her approach at the ...

The vaccine will only be available to those at high risk from COVID—excluding those who may need it to protect a relative or ...

Since becoming HHS Secretary, RFK Jr. has been deceptively weaponizing principles of evidence-based medicine against vaccines ...

In addition to its robotics capabilities, Nvidia unveiled its new NVLink Fusion offering, which allows customers to build ...

Gaithersburg’s Novavax has secured formal regulatory approval for its Covid vaccine. It's a major win, after the FDA delayed ...

SEC recommends to upgrade Corbevax from restricted use in emergency situation to new drug: Gireesh Babu, New Delhi Monday, ...